{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:28:47Z","timestamp":1790375327125,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T00:00:00Z","timestamp":1565049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Fellowship Grant"],"award-info":[{"award-number":["Fellowship Grant"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS58030"],"award-info":[{"award-number":["U01NS58030"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL132141"],"award-info":[{"award-number":["R01HL132141"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>People heterozygous for an activating mutation in protein kinase G1 (<jats:italic>PRKG1<\/jats:italic>, p.Arg177Gln) develop thoracic aortic aneurysms and dissections (TAAD) as young adults. Here we report that mice heterozygous for the mutation have a three-fold increase in basal protein kinase G (PKG) activity, and develop age-dependent aortic dilation. <jats:italic>Prkg1<\/jats:italic><jats:sup>R177Q\/+<\/jats:sup> aortas show increased smooth muscle cell apoptosis, elastin fiber breaks, and oxidative stress compared to aortas from wild type littermates. Transverse aortic constriction (TAC)\u2014to increase wall stress in the ascending aorta\u2014induces severe aortic pathology and mortality from aortic rupture in young mutant mice. The free radical-neutralizing vitamin B<jats:sub>12<\/jats:sub>-analog cobinamide completely prevents age-related aortic wall degeneration, and the unrelated anti-oxidant N-acetylcysteine ameliorates TAC-induced pathology. Thus, increased basal PKG activity induces oxidative stress in the aorta, raising concern about the widespread clinical use of PKG-activating drugs. Cobinamide could be a treatment for aortic aneurysms where oxidative stress contributes to the disease, including Marfan syndrome.<\/jats:p>","DOI":"10.1038\/s41467-019-11389-1","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T10:22:49Z","timestamp":1565086969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Aortic pathology from protein kinase G activation is prevented by an antioxidant vitamin B12 analog"],"prefix":"10.1038","volume":"10","author":[{"given":"Gerburg K.","family":"Schwaerzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"Kalyanaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren E.","family":"Casteel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D.","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghoe","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunhui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen","family":"Wahwah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemal H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna M.","family":"Milewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk L.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry R.","family":"Boss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4555-3541","authenticated-orcid":false,"given":"Renate B.","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,6]]},"reference":[{"key":"11389_CR1","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/heartjnl-2014-305648","volume":"100","author":"FM Davis","year":"2014","unstructured":"Davis, F. M., Rateri, D. L. & Daugherty, A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 100, 1498\u20131505 (2014).","journal-title":"Heart"},{"key":"11389_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrcardio.2016.211","volume":"14","author":"A Verstraeten","year":"2017","unstructured":"Verstraeten, A., Luyckx, I. & Loeys, B. Aetiology and management of hereditary aortopathy. Nat. Rev. Cardiol. 14, 197\u2013208 (2017).","journal-title":"Nat. Rev. Cardiol."},{"key":"11389_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-med-100415-022956","volume":"68","author":"DM Milewicz","year":"2017","unstructured":"Milewicz, D. M., Prakash, S. K. & Ramirez, F. Therapeutics targeting drivers of thoracic aortic aneurysms and acute aortic dissections: insights from predisposing genes and mouse models. Annu. Rev. Med. 68, 51\u201367 (2017).","journal-title":"Annu. Rev. Med."},{"key":"11389_CR4","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1161\/CIRCRESAHA.118.312436","volume":"124","author":"A Pinard","year":"2019","unstructured":"Pinard, A., Jones, G. T. & Milewicz, D. M. Genetics of thoracic and abdominal aortic diseases. Circ. Res. 124, 588\u2013606 (2019).","journal-title":"Circ. Res."},{"key":"11389_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jtcvs.2009.07.075","volume":"138","author":"G Ailawadi","year":"2009","unstructured":"Ailawadi, G. et al. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J. Thorac. Cardiovasc. Surg. 138, 1392\u20131399 (2009).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"11389_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/cvr\/cvq230","volume":"88","author":"S Inamoto","year":"2010","unstructured":"Inamoto, S. et al. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. Cardiovasc. Res. 88, 520\u2013529 (2010).","journal-title":"Cardiovasc. Res."},{"key":"11389_CR7","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1192149","volume":"332","author":"TM Holm","year":"2011","unstructured":"Holm, T. M. et al. Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332, 358\u2013361 (2011).","journal-title":"Science"},{"key":"11389_CR8","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","volume":"110","author":"W Xiong","year":"2012","unstructured":"Xiong, W., Meisinger, T., Knispel, R., Worth, J. M. & Baxter, B. T. MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome. Circ. Res. 110, e92\u2013e101 (2012).","journal-title":"Circ. Res."},{"key":"11389_CR9","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","volume":"35","author":"JR Cook","year":"2015","unstructured":"Cook, J. R. et al. Dimorphic effects of transforming growth factor-beta signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 911\u2013917 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"11389_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev-med-052914-091923","volume":"67","author":"A Buglioni","year":"2016","unstructured":"Buglioni, A. & Burnett, J. C. Jr. New pharmacological strategies to increase cGMP. Annu Rev. Med. 67, 229\u2013243 (2016).","journal-title":"Annu Rev. Med"},{"key":"11389_CR11","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1124\/pr.110.002907","volume":"62","author":"SH Francis","year":"2010","unstructured":"Francis, S. H., Busch, J. L., Corbin, J. D. & Sibley, D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharm. Rev. 62, 525\u2013563 (2010).","journal-title":"Pharm. Rev."},{"key":"11389_CR12","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2741\/1803","volume":"11","author":"TM Lincoln","year":"2006","unstructured":"Lincoln, T. M., Wu, X., Sellak, H., Dey, N. & Choi, C. S. Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front. Biosci. 11, 356\u2013367 (2006).","journal-title":"Front. Biosci."},{"key":"11389_CR13","doi-asserted-by":"publisher","first-page":"33367","DOI":"10.1074\/jbc.M707186200","volume":"282","author":"T Zhang","year":"2007","unstructured":"Zhang, T. et al. A cysteine-rich LIM-only protein mediates regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase. J. Biol. Chem. 282, 33367\u201333380 (2007).","journal-title":"J. Biol. Chem."},{"key":"11389_CR14","doi-asserted-by":"publisher","first-page":"16557","DOI":"10.1074\/jbc.M113.458729","volume":"288","author":"R Schwappacher","year":"2013","unstructured":"Schwappacher, R. et al. A molecular mechanism for therapeutic effects of cGMP-elevating agents in pulmonary arterial hypertension. J. Biol. Chem. 288, 16557\u201316566 (2013).","journal-title":"J. Biol. Chem."},{"key":"11389_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1161\/01.RES.88.1.103","volume":"88","author":"P Sinnaeve","year":"2001","unstructured":"Sinnaeve, P. et al. Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects. Circ. Res. 88, 103\u2013109 (2001).","journal-title":"Circ. Res"},{"key":"11389_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nm.4266","volume":"23","author":"J Oller","year":"2017","unstructured":"Oller, J. et al. Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome. Nat. Med. 23, 200\u2013212 (2017).","journal-title":"Nat. Med"},{"key":"11389_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.athoracsur.2011.07.016","volume":"93","author":"CM Lameijer","year":"2012","unstructured":"Lameijer, C. M., Tielliu, I. F., van Driel, M. F. & Zeebregts, C. J. Type B aortic dissection after the use of tadalafil. Ann. Thorac. Surg. 93, 651\u2013653 (2012).","journal-title":"Ann. Thorac. Surg."},{"key":"11389_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S0736-4679(01)00345-6","volume":"21","author":"G Famularo","year":"2001","unstructured":"Famularo, G., Polchi, S., Di Bona, G. & Manzara, C. Acute aortic dissection after cocaine and sildenafil abuse. J. Emerg. Med. 21, 78\u201379 (2001).","journal-title":"J. Emerg. Med."},{"key":"11389_CR19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/01.smj.0000240732.65859.aa","volume":"99","author":"A Nachtnebel","year":"2006","unstructured":"Nachtnebel, A., Stollberger, C., Ehrlich, M. & Finsterer, J. Aortic dissection after sildenafil-induced erection. South Med. J. 99, 1151\u20131152 (2006).","journal-title":"South Med. J."},{"key":"11389_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.7861\/clinmedicine.14-1-58","volume":"14","author":"AP Croft","year":"2014","unstructured":"Croft, A. P., Nader, K. & Arulanantham, N. A very unusual headache. Clin. Med. (Lond.) 14, 58\u201360 (2014).","journal-title":"Clin. Med. (Lond.)"},{"key":"11389_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S2213-2600(14)70013-X","volume":"2","author":"AR Goudie","year":"2014","unstructured":"Goudie, A. R., Lipworth, B. J., Hopkinson, P. J., Wei, L. & Struthers, A. D. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. Lancet Respir. Med. 2, 293\u2013300 (2014).","journal-title":"Lancet Respir. Med"},{"key":"11389_CR22","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.ajhg.2013.06.019","volume":"93","author":"DC Guo","year":"2013","unstructured":"Guo, D. C. et al. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. Am. J. Hum. Genet. 93, 398\u2013404 (2013).","journal-title":"Am. J. Hum. Genet."},{"key":"11389_CR23","doi-asserted-by":"publisher","first-page":"14772","DOI":"10.1073\/pnas.97.26.14772","volume":"97","author":"WR Dostmann","year":"2000","unstructured":"Dostmann, W. R. et al. Highly specific, membrane-permeant peptide blockers of cGMP-dependent protein kinase Ialpha inhibit NO-induced cerebral dilation. Proc. Natl. Acad. Sci. USA 97, 14772\u201314777 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11389_CR24","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.bjp.0707181","volume":"150","author":"AW Chung","year":"2007","unstructured":"Chung, A. W. et al. Endothelial dysfunction and compromised eNOS\/Akt signaling in the thoracic aorta during the progression of Marfan syndrome. Br. J. Pharm. 150, 1075\u20131083 (2007).","journal-title":"Br. J. Pharm."},{"key":"11389_CR25","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/eci.12662","volume":"46","author":"M Gago-Diaz","year":"2016","unstructured":"Gago-Diaz, M. et al. PRKG1 and genetic diagnosis of early-onset thoracic aortic disease. Eur. J. Clin. Invest. 46, 787\u2013794 (2016).","journal-title":"Eur. J. Clin. Invest."},{"key":"11389_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E. R. et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407\u2013411 (2003).","journal-title":"Nat. Genet"},{"key":"11389_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1172\/JCI69666","volume":"124","author":"EM Gallo","year":"2014","unstructured":"Gallo, E. M. et al. Angiotensin II-dependent TGF-beta signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J. Clin. Invest. 124, 448\u2013460 (2014).","journal-title":"J. Clin. Invest"},{"key":"11389_CR28","doi-asserted-by":"crossref","unstructured":"Daugherty, A., Chen, Z., Sawada, H., Rateri, D. L. & Sheppard, M. B. Transforming growth factor-beta in thoracic aortic Aneurysms: good, bad, or irrelevant? J. Am. Heart Assoc. 6, e005221 (2017).","DOI":"10.1161\/JAHA.116.005221"},{"key":"11389_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrd3403","volume":"10","author":"GR Drummond","year":"2011","unstructured":"Drummond, G. R., Selemidis, S., Griendling, K. K. & Sobey, C. G. Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453\u2013471 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"11389_CR30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.freeradbiomed.2005.10.056","volume":"40","author":"HM Shen","year":"2006","unstructured":"Shen, H. M. & Liu, Z. G. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 40, 928\u2013939 (2006).","journal-title":"Free Radic. Biol. Med."},{"key":"11389_CR31","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/nm1335","volume":"11","author":"K Yoshimura","year":"2005","unstructured":"Yoshimura, K. et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat. Med. 11, 1330\u20131338 (2005).","journal-title":"Nat. Med."},{"key":"11389_CR32","doi-asserted-by":"publisher","first-page":"16406","DOI":"10.1074\/jbc.C100079200","volume":"276","author":"JW Soh","year":"2001","unstructured":"Soh, J. W. et al. Protein kinase G activates the JNK1 pathway via phosphorylation of MEKK1. J. Biol. Chem. 276, 16406\u201316410 (2001).","journal-title":"J. Biol. Chem."},{"key":"11389_CR33","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2004.12.041","volume":"120","author":"H Kamata","year":"2005","unstructured":"Kamata, H. et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649\u2013661 (2005).","journal-title":"Cell"},{"key":"11389_CR34","doi-asserted-by":"publisher","first-page":"34301","DOI":"10.1074\/jbc.274.48.34301","volume":"274","author":"P Komalavilas","year":"1999","unstructured":"Komalavilas, P., Shah, P. K., Jo, H. & Lincoln, T. M. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274, 34301\u201334309 (1999).","journal-title":"J. Biol. Chem."},{"key":"11389_CR35","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1111\/bph.13532","volume":"174","author":"G Teixeira","year":"2017","unstructured":"Teixeira, G. et al. Therapeutic potential of NADPH oxidase 1\/4 inhibitors. Br. J. Pharm. 174, 1647\u20131669 (2017).","journal-title":"Br. J. Pharm."},{"key":"11389_CR36","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.cellsig.2011.06.019","volume":"23","author":"J Vogt","year":"2011","unstructured":"Vogt, J., Traynor, R. & Sapkota, G. P. The specificities of small molecule inhibitors of the TGFss and BMP pathways. Cell Signal. 23, 1831\u20131842 (2011).","journal-title":"Cell Signal"},{"key":"11389_CR37","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1128\/MCB.24.24.10703-10717.2004","volume":"24","author":"E Pedruzzi","year":"2004","unstructured":"Pedruzzi, E. et al. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 24, 10703\u201310717 (2004).","journal-title":"Mol. Cell. Biol."},{"key":"11389_CR38","doi-asserted-by":"publisher","first-page":"34263","DOI":"10.1074\/jbc.273.51.34263","volume":"273","author":"JD Chiche","year":"1998","unstructured":"Chiche, J. D. et al. Adenovirus-mediated gene transfer of cGMP-dependent protein kinase increases the sensitivity of cultured vascular smooth muscle cells to the antiproliferative and pro-apoptotic effects of nitric oxide\/cGMP. J. Biol. Chem. 273, 34263\u201334271 (1998).","journal-title":"J. Biol. Chem."},{"key":"11389_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep20831","volume":"6","author":"J Jiang","year":"2016","unstructured":"Jiang, J. et al. Hydrogen sulfide\u2013mechanisms of toxicity and development of an antidote. Sci. Rep. 6, 20831 (2016).","journal-title":"Sci. Rep."},{"key":"11389_CR40","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nm.2603","volume":"18","author":"O Prysyazhna","year":"2012","unstructured":"Prysyazhna, O., Rudyk, O. & Eaton, P. Single atom substitution in mouse protein kinase G eliminates oxidant sensing to cause hypertension. Nat. Med. 18, 286\u2013290 (2012).","journal-title":"Nat. Med"},{"key":"11389_CR41","doi-asserted-by":"publisher","first-page":"8262","DOI":"10.1074\/jbc.C117.787358","volume":"292","author":"H Kalyanaraman","year":"2017","unstructured":"Kalyanaraman, H., Zhuang, S., Pilz, R. B. & Casteel, D. E. The activity of cGMP-dependent protein kinase Ialpha is not directly regulated by oxidation-induced disulfide formation at cysteine 43. J. Biol. Chem. 292, 8262\u20138268 (2017).","journal-title":"J. Biol. Chem."},{"key":"11389_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1681\/ASN.2015030302","volume":"27","author":"YH You","year":"2016","unstructured":"You, Y. H., Quach, T., Saito, R., Pham, J. & Sharma, K. Metabolomics reveals a key role for fumarate in mediating the effects of NADPH oxidase 4 in diabetic kidney disease. J. Am. Soc. Nephrol. 27, 466\u2013481 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"11389_CR43","doi-asserted-by":"publisher","first-page":"18121","DOI":"10.1073\/pnas.1009700107","volume":"107","author":"M Zhang","year":"2010","unstructured":"Zhang, M. et al. NADPH oxidase-4 mediates protection against chronic load-induced stress in mouse hearts by enhancing angiogenesis. Proc. Natl. Acad. Sci. USA 107, 18121\u201318126 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11389_CR44","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/CIRCRESAHA.111.300171","volume":"112","author":"S Matsushima","year":"2013","unstructured":"Matsushima, S. et al. Broad suppression of NADPH oxidase activity exacerbates ischemia\/reperfusion injury through inadvertent downregulation of hypoxia-inducible factor-1alpha and upregulation of peroxisome proliferator-activated receptor-alpha. Circ. Res. 112, 1135\u20131149 (2013).","journal-title":"Circ. Res."},{"key":"11389_CR45","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","volume":"110","author":"B Lassegue","year":"2012","unstructured":"Lassegue, B., San Martin, A. & Griendling, K. K. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ. Res. 110, 1364\u20131390 (2012).","journal-title":"Circ. Res."},{"key":"11389_CR46","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jvs.2017.09.030","volume":"68","author":"W Wang","year":"2018","unstructured":"Wang, W. et al. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease. J. Vasc. Surg. 68, 1538\u20131550 e1532 (2018).","journal-title":"J. Vasc. Surg."},{"key":"11389_CR47","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3892\/mmr.2017.7169","volume":"16","author":"X Li","year":"2017","unstructured":"Li, X. et al. Curcumin attenuates the development of thoracic aortic aneurysm by inhibiting VEGF expression and inflammation. Mol. Med. Rep. 16, 4455\u20134462 (2017).","journal-title":"Mol. Med. Rep."},{"key":"11389_CR48","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1172\/JCI74783","volume":"124","author":"T Moore-Morris","year":"2014","unstructured":"Moore-Morris, T. et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 124, 2921\u20132934 (2014).","journal-title":"J. Clin. Invest."},{"key":"11389_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.freeradbiomed.2016.02.031","volume":"94","author":"XH Liu","year":"2016","unstructured":"Liu, X. H. et al. NADPH oxidase 4 contributes to connective tissue growth factor expression through Smad3-dependent signaling pathway. Free Radic. Biol. Med. 94, 174\u2013184 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"11389_CR50","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.116.025144","volume":"135","author":"Y Oshima","year":"2017","unstructured":"Oshima, Y., Tanimoto, T., Yuji, K. & Tojo, A. Association between aortic dissection and systemic exposure of vascular endothelial growth factor pathway inhibitors in the Japanese Adverse Drug Event Report Database. Circulation 135, 815\u2013817 (2017).","journal-title":"Circulation"},{"key":"11389_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000355253","volume":"127","author":"F Del Porto","year":"2014","unstructured":"Del Porto, F. et al. The multitasking role of macrophages in Stanford type A acute aortic dissection. Cardiology 127, 123\u2013129 (2014).","journal-title":"Cardiology"},{"key":"11389_CR52","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1161\/CIRCRESAHA.117.310563","volume":"120","author":"J Chen","year":"2017","unstructured":"Chen, J. et al. Loss of smooth muscle alpha-actin leads to NF-kappaB-dependent increased sensitivity to angiotensin II in smooth muscle cells and aortic enlargement. Circ. Res. 120, 1903\u20131915 (2017).","journal-title":"Circ. Res."},{"key":"11389_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.vph.2009.10.005","volume":"52","author":"HH Yang","year":"2010","unstructured":"Yang, H. H., van Breemen, C. & Chung, A. W. Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress. Vasc. Pharm. 52, 37\u201345 (2010).","journal-title":"Vasc. Pharm."},{"key":"11389_CR54","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2018.02.023","volume":"118","author":"F Jimenez-Altayo","year":"2018","unstructured":"Jimenez-Altayo, F. et al. Redox stress in Marfan syndrome: dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm. Free Radic. Biol. Med. 118, 44\u201358 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"11389_CR55","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1161\/01.ATV.0000257552.94483.14","volume":"27","author":"ML McCormick","year":"2007","unstructured":"McCormick, M. L., Gavrila, D. & Weintraub, N. L. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 27, 461\u2013469 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"11389_CR56","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1089\/ars.2013.5507","volume":"20","author":"U Raaz","year":"2014","unstructured":"Raaz, U. et al. Hemodynamic regulation of reactive oxygen species: implications for vascular diseases. Antioxid. Redox Signal. 20, 914\u2013928 (2014).","journal-title":"Antioxid. Redox Signal"},{"key":"11389_CR57","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/S0008-6363(03)00523-6","volume":"59","author":"J Ejiri","year":"2003","unstructured":"Ejiri, J. et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: protective role of statin and angiotensin II type 1 receptor blocker. Cardiovasc. Res. 59, 988\u2013996 (2003).","journal-title":"Cardiovasc. Res"},{"key":"11389_CR58","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.freeradbiomed.2016.07.013","volume":"97","author":"E Di Marco","year":"2016","unstructured":"Di Marco, E. et al. NOX4-derived reactive oxygen species limit fibrosis and inhibit proliferation of vascular smooth muscle cells in diabetic atherosclerosis. Free Radic. Biol. Med. 97, 556\u2013567 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"11389_CR59","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/CIRCRESAHA.112.267054","volume":"110","author":"K Schroder","year":"2012","unstructured":"Schroder, K. et al. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ. Res. 110, 1217\u20131225 (2012).","journal-title":"Circ. Res"},{"key":"11389_CR60","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/ATVBAHA.116.307096","volume":"36","author":"DJ Fulton","year":"2016","unstructured":"Fulton, D. J. & Barman, S. A. Clarity on the isoform-specific roles of NADPH oxidases and NADPH oxidase-4 in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 36, 579\u2013581 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"11389_CR61","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.112.269068","volume":"110","author":"RM Touyz","year":"2012","unstructured":"Touyz, R. M. & Montezano, A. C. Vascular Nox4: a multifarious NADPH oxidase. Circ. Res. 110, 1159\u20131161 (2012).","journal-title":"Circ. Res"},{"key":"11389_CR62","doi-asserted-by":"publisher","first-page":"15565","DOI":"10.1073\/pnas.1002178107","volume":"107","author":"J Kuroda","year":"2010","unstructured":"Kuroda, J. et al. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl. Acad. Sci. USA 107, 15565\u201315570 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"11389_CR63","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm501565k","volume":"58","author":"A Chan","year":"2015","unstructured":"Chan, A. et al. Nitrocobinamide, a new cyanide antidote that can be administered by intramuscular injection. J. Med. Chem. 58, 1750\u20131759 (2015).","journal-title":"J. Med. Chem."},{"key":"11389_CR64","doi-asserted-by":"publisher","first-page":"L1027","DOI":"10.1152\/ajplung.00167.2015","volume":"309","author":"Y Han","year":"2015","unstructured":"Han, Y. et al. SGLT inhibitors attenuate NO-dependent vascular relaxation in the pulmonary artery but not in the coronary artery. Am. J. Physiol. Lung Cell Mol. Physiol. 309, L1027\u2013L1036 (2015).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"11389_CR65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S0163-7258(98)00063-1","volume":"82","author":"WR Dostmann","year":"1999","unstructured":"Dostmann, W. R. et al. Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper. Pharm. Ther. 82, 373\u2013387 (1999).","journal-title":"Pharm. Ther."},{"key":"11389_CR66","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1172\/JCI83778","volume":"126","author":"SQ Kuang","year":"2016","unstructured":"Kuang, S. Q. et al. FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. J. Clin. Invest. 126, 948\u2013961 (2016).","journal-title":"J. Clin. Invest"},{"key":"11389_CR67","doi-asserted-by":"publisher","first-page":"ra48","DOI":"10.1126\/scisignal.2004911","volume":"7","author":"H Kalyanaraman","year":"2014","unstructured":"Kalyanaraman, H. et al. Nongenomic thyroid hormone signaling occurs through a plasma membrane-localized receptor. Sci. Signal. 7, ra48 (2014).","journal-title":"Sci. Signal."},{"key":"11389_CR68","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"11389_CR69","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1093\/hmg\/ddq066","volume":"19","author":"J Cao","year":"2010","unstructured":"Cao, J. et al. Thoracic aortic disease in tuberous sclerosis complex: molecular pathogenesis and potential therapies in Tsc2+\/- mice. Hum. Mol. Genet. 19, 1908\u20131920 (2010).","journal-title":"Hum. Mol. Genet."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11389-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11389-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11389-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:47:50Z","timestamp":1671238070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-11389-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,6]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["11389"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-11389-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,6]]},"assertion":[{"value":"12 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3533"}}